Alphavirus replicon particles as candidate HIV vaccines

IUBMB Life

Volumn 53, Issue 4-5, 2002, Pages 209-211

  Davis, Nancy L ^a   West, Ande ^a   Reap, Elizabeth ^b   MacDonald, Gene ^a   Collier, Martha ^a   Dryga, Sergey ^b   Maughan, Maureen ^b   Connell, Mary ^c   Walker, Chris ^c   McGrath, Kathryn ^a   Cecil, Chad ^a   Ping, Li Hua ^a   Frelinger, Jeff ^a   Olmsted, Robert ^b   Keith, Paula ^b   Swanstrom, Ronald ^a   Williamson, Carolyn ^d   Johnson, Philip ^c   Montefiori, David ^e   Johnston, Robert E ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b AlphaVax Inc   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e DUKE UNIVERSITY   (United States)

Author keywords

Dendritic cell targeting in vivo; Mucosal SIV challenge in macaques; SIV sm E660 intrarectal challenge; Venezuelan equine encephalitis virus replicon particles

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; GLYCOPROTEIN; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; GREEN FLUORESCENT PROTEIN; HEMAGGLUTININ; PHOTOPROTEIN;

ALPHA VIRUS; ANIMAL MODEL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLUENZA VIRUS; LEUKOCYTE COUNT; MACACA; MOUSE; NONHUMAN; REPLICON; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS PARTICLE; ANIMAL; CLINICAL TRIAL; GENETICS; HUMAN; METABOLISM; MUTATION; REVIEW; SOUTH AFRICA; TIME;

AIDS VACCINES; ANIMAL; CLINICAL TRIALS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; GENE PRODUCTS, GAG; GLYCOPROTEINS; HEMAGGLUTININS; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HUMAN; LUMINESCENT PROTEINS; MICE; MUTATION; SOUTH AFRICA; TIME FACTORS; ANIMALS; GREEN FLUORESCENT PROTEINS; HUMANS;

ALPHAVIRUS; ANIMALIA; EQUIDAE; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; MACACA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0035991717     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540212657     Document Type: Conference Paper

References (7)

1. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis
2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
3. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters
4. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
5. Pathogenic diversity of simian immunodeficiency viruses
6. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles